RSS

Crown Bioscience (CrownBio)

Global drug discovery and development services company, Crown Bioscience, has been selected as a strategic partner by Phanes Therapeutics to accelerate the discovery and development of novel oncology agents. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

An integrated oncology platform from Crown Bioscience has helped to advance the preclinical development of a HERA-GITRL immunotherapy from Apogenix for non-small cell lung cancer (NSCLC) and head and neck cancer. more

Technology

Crown Bioscience has announced the publication of two new scientific papers indicating that the FATZO model is a significantly improved rodent model for obesity, dysmetabolism and type 2 diabetes for pre-clinical studies. more

News

An agreement between Crown Bioscience (CrownBio) and The Jackson Laboratory (JAX) has been announced to improve the development and accessibility of innovative research models and pre-clinical services to the global biomedical research community. more

News